Still, GLP-1 use may lead to hundreds of thousands of patients experiencing gastrointestinal side effects, according to the researchers
Weight Loss and Supplements Welcome to Our Medical Weight Loss Program Congratulations on taking the first step toward your health and wellness journey
But on the negative side, gastroparesis and worsening GI symptoms feature prominently in EDS community discussions
Some GLP-1 antagonists can also help treat obesity
In clinical trials funded by Novo Nordisk, researchers found Wegovy reduces the risk of serious cardiovascular events such as heart attack, stroke, or death in adults with obesity or overweight who also have cardiovascular disease
Think protein-focused mini meals about one-half to three-quarters of a cup of food at a time, depending on what your body can comfortably handle